Abstract
The idea that Vitamin D analogues may be considered an option for the treatment of the vitiligo arises from the casual observation of the occurrence of cutaneous perilesional hyperpigmentation after their application on psoriatic plaques together with phototherapy [6, 14, 23, 27, 28]. Starting from this clinical evidence, several in vitro and in vivo data support the therapeutic role of calcipotriol and tacalcitol for vitiligo (Table 3.2.3.1). Skin cells, including keratinocytes, melanocytes, and dermal fibroblasts possess Vitamin D receptors (VDR), the activation of which induces several genes associated with proliferation and differentiation, and with the inflammatory reaction. Exposure of human melano-cytes to Vitamin D promotes tyrosinase activity and melanogenesis, together with the up-regulation of c-Kit as well as morphological modifications, mainly increases the number and length of the dendrites. With regard to keratinocytes, Vitamin D produces differentiation, decreased proliferation, and the release of the proinflammatory cytokines IL-8 and IL-6, and increased production of IL-10. In vitiligo skin, both melanocytes and keratinocytes have been shown to possess an alteration of the Ca++ uptake and a decreased intracellular concentration of the ion, which could compromise the melanogenesis by increasing the level of reduced thi-oredoxin, which inhibits tyrosinase [6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ada S, Sahin S, Boztepe G et al (2005) No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo. Photodermatol Photo-immunol Photomed 21:79–83
Amano H, Abe M, Ishikawa O (2008) First case report of topical tacalcitol for vitiligo repigmentation. Pediatr Dermatol 25:262–264
Ameen M, Exarchou V, Chu AC (2001) Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 145:476–479
Arca E, Tastan HB, Erbil AH et al (2006) Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol 33:338–343
Baysal V, Vildirim M, Erel A, Kesici D (2003) Is the combination of calcipotriol and PUVA effective in vitiligo? JEADV 17:299–302
Birlea SA, Costin GE, Norris DA (2008) Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets 9:345–359
Cherif F, Azaiz MI, Ben Hamida A et al (2003) Calcipotriol and PUVA as treatment for vitiligo. Dermatol Ondine J 9:4
Chiaverini C, Passeron T, Ortonne JP (2002) Treatment of vitiligo by topical calcipotriol. JEADV 16:137–138
Ermis O, Alpsoy E, Cetin L, Yilmaz E (2001) Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 145:472–475
Gargoom AM, Duweb GA, Elzorghany AH et al (2004) Calcipotriol in the treatment of childood vitiligo. Int J Clin Pharmacol Res 24:11–14
Gawkrodger DJ, Ormerod AD, Shaw L et al (2008) Guideline for the diagnosis and management of vitiligo. Br J Dermatol 159:1051–1076
Goldinger SM, Dummer R, Schmid P et al (2007) Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. JEADV 21:504–508
Goktas EO, Aydin F, Senturk N et al (2006) Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. JEADV 20:553–557
Guilhou JJ (1998) The therapeutic effects of vitamin D3 and its analogues in psoriasis. Exp Opin Invest Drugs 7:77–84
Hartmann A, Lurz C, Hamm H et al (2005) Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol 44:736–742
Katayama I, Ashida M, Maeda A et al (2003) Open trial of topical tacalcitol [1alpha24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of cKit mRNA by cultured melanocytes. Eur J Dermatol 13:372–376
Kullavanijaya P, Lim HW (2004) Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photoderm Photoimmunol Photomed 20:248–251
Kumaran MS, Kaur I, Kumar B (2006) Effect of topical cal-cipotriol, betamethasone dipropionate and their combinat-tion in the treatment of localized vitiligo. JEADV 20:269–273
Leone G, Pacifico A (2005) Profile of clinical efficacy and safety of topical tacalcitol. Acta Biomed 76:13–19
Leone G, Pacifico A, Iacovelli P et al (2006) Tacalcitol and narrow-band phototherapy in patients with vitiligo. Clin Exp Dermatol 31:200–205
Lotti T, Buggiani G, Troiano M et al (2008) Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol Ther 21(1):s20–s26
Lu-yan T, Wen-wen F, Lei-hong X et al (2006) Topical tacal-citol and 308-nm monochromatic excimer light: a synergis-tic combination for the treatment of vitiligo. Photoderm Photoimmunol Photomed 22:310–314
Ortonne JP, Kaufmann R, Lecha M, Goodfield M (2004) Efficacy of treatment with calcipotriol/betamethasone dipro-pionate followed by calcipotriol alone compared with tacal-citol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. Dermatology 209:308–313
Parsad D, Saini R, Nagpal R (1999) Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 16:317–320
Rodriguez-Martìn M, Garcia Bustinduy M, Saez rodriguez M, Noda Cabrera A (2009) Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. Br J Dermatol 160:409–414
Travis LB, Silverberg NB (2004) Calcipotriene and corticos-teroids combination therapy for vitiligo. Pediatr Dermatol 21:495–498
Takahashi H, Ibe M, Kinouchi M et al (2003) Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 31:21–28
Watabe H, Soma Y, Kawa Y et al (2002) Differentiation of murine melanocyte precursore induced by 1,25 dihy-droxyvitamin D3 is associated with the stimulation of endothelin B receptor expression. J Invest Dermatol 119:583–589
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Picardo, M. (2010). Vitamin D Analogues. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69361-1_40
Download citation
DOI: https://doi.org/10.1007/978-3-540-69361-1_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69360-4
Online ISBN: 978-3-540-69361-1
eBook Packages: MedicineMedicine (R0)